Strategies for improving the efficacy of immunotherapy in hepatocellular carcinoma

Y Zhu, LX Qin - Hepatobiliary & Pancreatic Diseases International, 2022 - Elsevier
Primary liver cancer, mainly hepatocellular carcinoma (HCC), is the sixth most diagnosed
cancer and third leading cause of cancer-related death globally. Recently, immunotherapies …
被引用次数：17 相关文章

Strategies for improving the efficacy of immunotherapy in hepatocellular carcinoma

Y Zhu, LX Qin - Hepatobiliary & pancreatic diseases …, 2022 - pubmed.ncbi.nlm.nih.gov
Primary liver cancer, mainly hepatocellular carcinoma (HCC), is the sixth most diagnosed
cancer and third leading cause of cancer-related death globally. Recently, immunotherapies …